Literature DB >> 7263765

Neurotensin and medullary carcinoma of the thyroid gland.

I Baća, H Schmidt-Gayk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7263765     DOI： 10.1007/BF00403370

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  5 in total

1.  Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry.

Authors:  J M Polak; S N Sullivan; S R Bloom; A M Buchan; P Facer; M R Brown; A G Pearse
Journal:  Nature       Date:  1977-11-10       Impact factor: 49.962

2.  The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami.

Authors:  R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1973-10-10       Impact factor: 5.157

3.  Isolation of a tridecapeptide from bovine intestinal tissue and its partial characterization as neurotensin.

Authors:  P Kitabgi; R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1976-11-25       Impact factor: 5.157

4.  Calcitonin as a tumor marker. Use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma.

Authors:  D Goltzman; J T Potts; R C Ridgway; F Maloof
Journal:  N Engl J Med       Date:  1974-05-09       Impact factor: 91.245

5.  Characterization of neurotensin production by a line of rat medullary thyroid carcinoma cells.

Authors:  F N Zeytinoğlu; R F Gagel; A H Tashjian; R A Hammer; S E Leeman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205
  5 in total
  1 in total

1.  Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy.

Authors:  Zherui Wu; Daniel Martinez-Fong; Jean Trédaniel; Patricia Forgez
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-17       Impact factor: 5.555
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.